Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Bilgehan Ibibik"'
Autor:
Pelin Gülizar Ersan, Muzaffer Yildirim, Tugce Bildik, Unal Metin Tokat, Ihsan Gursel, Nilsu Turay, Tugce Yildirim, Ozgur Sahin, Bilgehan Ibibik, Irem Evcili
Publikováno v:
Immunology Letters
Tumor-derived exosomes (TEXs) could be harnessed as an immunotherapeutic cancer vaccine. These nanovesicles are inherently possesses rich tumor antigen reservoirs. Due to their undesirable features such as poor or limited immunogenicity as well as fa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1a3877aab441c8b8954c98998994805a
https://doi.org/10.1016/j.imlet.2021.08.004
https://doi.org/10.1016/j.imlet.2021.08.004
Autor:
Gulay Korukluoglu, İlayda Baydemir, Tugce Yildirim, Muzaffer Yildirim, Irem Evcili, Sefa Burak Cam, Ismail Selim Yildirim, Nese Guvencli, Ihsan Gursel, Naz Surucu Yilmaz, Yasemin Ceylan, İsmail Cem Yılmaz, Osman Erganiş, Basak Kayaoglu, Yagmur Aydin, Mayda Gursel, Hakan Enul, Emre Mert İpekoğlu, Fahriye Sarac, Asli Gulce Bartan, Merve Gizer, Gamze Aykut, Cumhur Adiay, Hasan Ersin Zeytin, Petek Korkusuz, Bilgi Gungor, Eda Çiftci Dede, Hivda Polat, Ihsan Cihan Ayanoglu, Şaban Tekin, Tugce Bildik, Berfu Saraydar, Hatice Asena Sanli, Nilsu Turay, Irem Abras, Artun Bulbul, Bilgehan Ibibik, Serdar Uzar
Publikováno v:
Allergy
Background Vaccines that incorporate multiple SARS‐CoV‐2 antigens can further broaden the breadth of virus‐specific cellular and humoral immunity. This study describes the development and immunogenicity of SARS‐CoV‐2 VLP vaccine that incorp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::865d14909b6f9a9f0801a3481d912e03
https://pubmed.ncbi.nlm.nih.gov/34519053
https://pubmed.ncbi.nlm.nih.gov/34519053
Autor:
Ismail Selim Yildirim, Cumhur Adiay, Şaban Tekin, Hakan Enul, Eda Çiftci Dede, Muzaffer Yildirim, Serdar Uzar, Bilgehan Ibibik, Sefa Burak Cam, Tugce Yildirim, Emre Mert İpekoğlu, Nilsu Turay, Tugce Bildik, Artun Bulbul, Asli Gulce Bartan, Mayda Gursel, Hatice Asena Sanli, Ihsan Gursel, Naz Surucu Yilmaz, Irem Abras, Fahriye Sarac, Ismail Yilmaz C, Berfu Saraydar, Bilgi Gungor, Hivda Polat, Yasemin Ceylan, Basak Kayaoglu, Ihsan Cihan Ayanoglu, Irem Evcili, Osman Erganiş, Nese Guvencli, Yagmur Aydin, Merve Gizer, Gamze Aykut, Hasan Ersin Zeytin, İlayda Baydemir, Petek Korkusuz
Background Vaccines that incorporate multiple SARS-CoV-2 antigens can further broaden the breadth of virus-specific cellular and humoral immunity. This study describes the development and immunogenicity of SARS-CoV-2 VLP vaccine that incorporates the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6e01f71c2410d086b5b7d89f1d6c7456
https://doi.org/10.22541/au.162615692.26217047/v2
https://doi.org/10.22541/au.162615692.26217047/v2
Autor:
Ismail Yilmaz C, Emre Ipekoglu, Muzaffer Yildirim, Irem Evcili, Naz Yilmaz, Artun Bulbul, Nilsu Turay, Yagmur Aydin, Nese Guvencli, Bilgi Gungor, Berfu Saraydar, Asli Gulce Bartan, Bilgehan Ibibik, Tugce Bildik, İlayda Baydemir, Sefa Burak Cam, Eda Ciftci Dede, Merve Gizer, Osman Erganis, Fahriye Sarac, Serdar Uzar, Hakan Enul, Cumhur Adiay, Gamze Aykut, Hivda Polat, Saban Tekin, Hasan E. Zeytin, Petek Korkusuz, Ihsan Gursel, Mayda Gursel
Background Vaccines that incorporate multiple SARS-CoV-2 antigens can further broaden the breadth of virus-specific cellular and humoral immunity. This study describes the development and immunogenicity of SARS-CoV-2 VLP vaccine that incorporates the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ab8b223beb234477432c2451dd1eabd5
https://doi.org/10.22541/au.162615692.26217047/v1
https://doi.org/10.22541/au.162615692.26217047/v1